These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9619868)
1. Activated lymphocytes from breast cancer patients express the characteristics of type 2 helper cells--a possible role for breast cancer-associated p43. Rosen HR; Ausch C; Reinerova M; Zaspin E; Renner K; Rosen AC; Schiessel R; Moroz C Cancer Lett; 1998 May; 127(1-2):129-34. PubMed ID: 9619868 [TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43. Reinerová M; Veselovská Z; Ausch C; Rosen HR Neoplasma; 1996; 43(6):363-6. PubMed ID: 8996559 [TBL] [Abstract][Full Text] [Related]
3. Immunosuppression by breast cancer associated p43-effect of immunomodulators. Rosen HR; Ausch C; Reiner G; Reinerova M; Svec J; Tüchler H; Schiessel R; Moroz C Breast Cancer Res Treat; 1996; 41(2):171-6. PubMed ID: 8944335 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of lymphocyte mitogenesis by breast cancer-associated p43. Rosen HR; Ausch C; Reiner G; Reinerova M; Svec J; Tüchler H; Schiessel R; Moroz C Cancer Lett; 1994 Jul; 82(1):105-11. PubMed ID: 8033063 [TBL] [Abstract][Full Text] [Related]
5. The novel cytokine p43 induces IL-12 production in macrophages via NF-kappaB activation, leading to enhanced IFN-gamma production in CD4+ T cells. Kim E; Kim SH; Kim S; Kim TS J Immunol; 2006 Jan; 176(1):256-64. PubMed ID: 16365417 [TBL] [Abstract][Full Text] [Related]
6. Identification of women with early breast cancer by analysis of p43-positive lymphocytes. Auerbach L; Hellan M; Stierer M; Rosen AC; Ausch C; Obwegeser R; Kubista E; Wolf G; Rosen HR; Panzer S Br J Cancer; 1999 May; 80(5-6):874-8. PubMed ID: 10360668 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750 [TBL] [Abstract][Full Text] [Related]
8. Cycloastragenol mediates activation and proliferation suppression in concanavalin A-induced mouse lymphocyte pan-activation model. Sun C; Jiang M; Zhang L; Yang J; Zhang G; Du B; Ren Y; Li X; Yao J Immunopharmacol Immunotoxicol; 2017 Jun; 39(3):131-139. PubMed ID: 28290732 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancer. Goedegebuure PS; Douville CC; Doherty JM; Linehan DC; Lee KY; Ganguly EK; Eberlein TJ Cell Immunol; 1997 Feb; 175(2):150-6. PubMed ID: 9023420 [TBL] [Abstract][Full Text] [Related]
10. Exercise and lymphocyte activation following chemotherapy for breast cancer. Hutnick NA; Williams NI; Kraemer WJ; Orsega-Smith E; Dixon RH; Bleznak AD; Mastro AM Med Sci Sports Exerc; 2005 Nov; 37(11):1827-35. PubMed ID: 16286849 [TBL] [Abstract][Full Text] [Related]
11. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Yin Z; Braun J; Neure L; Wu P; Liu L; Eggens U; Sieper J Arthritis Rheum; 1997 Oct; 40(10):1788-97. PubMed ID: 9336412 [TBL] [Abstract][Full Text] [Related]
12. Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Diaz-Mitoma F; Kumar A; Karimi S; Kryworuchko M; Daftarian MP; Creery WD; Filion LG; Cameron W Clin Exp Immunol; 1995 Oct; 102(1):31-9. PubMed ID: 7554396 [TBL] [Abstract][Full Text] [Related]
13. Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast. Kuerer HM; Peoples GE; Sahin AA; Murray JL; Singletary SE; Castilleja A; Hunt KK; Gershenson DM; Ioannides CG J Interferon Cytokine Res; 2002 May; 22(5):583-92. PubMed ID: 12060497 [TBL] [Abstract][Full Text] [Related]
14. T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands. Karasar P; Esendagli G Breast Cancer Res Treat; 2014 Jun; 145(3):605-14. PubMed ID: 24816762 [TBL] [Abstract][Full Text] [Related]
15. Immune dysfunction and micrometastases in women with breast cancer. Campbell MJ; Scott J; Maecker HT; Park JW; Esserman LJ Breast Cancer Res Treat; 2005 May; 91(2):163-71. PubMed ID: 15868444 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. Paliard X; de Waal Malefijt R; Yssel H; Blanchard D; Chrétien I; Abrams J; de Vries J; Spits H J Immunol; 1988 Aug; 141(3):849-55. PubMed ID: 2969394 [TBL] [Abstract][Full Text] [Related]
17. Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells. Adams PW; Lee HS; Waldman WJ; Sedmak DD; Morgan CJ; Ward JS; Orosz CG J Immunol; 1992 Jun; 148(12):3753-60. PubMed ID: 1351087 [TBL] [Abstract][Full Text] [Related]
18. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy. Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679 [TBL] [Abstract][Full Text] [Related]
20. Virus-induced interferon alpha/beta (IFN-alpha/beta) production by T cells and by Th1 and Th2 helper T cell clones: a study of the immunoregulatory actions of IFN-gamma versus IFN-alpha/beta on functions of different T cell populations. Klimpel GR; Infante AJ; Patterson J; Hess CB; Asuncion M Cell Immunol; 1990 Jul; 128(2):603-18. PubMed ID: 2162739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]